novo nordisk's semaglutide failed to slow alzheimer's disease progression Drug maker Nordisk has announced that its weight-loss drug down the decline in memory and thinking in people with early disease. This disappointing news will come Novo Nordisk says Alzheimer's drug
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




























